John Birk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
John Birk has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Aksenov
University of Connecticut
41 shared publications - Ali Lotfi
Department of Chemistry, University of Connecticut
41 shared publications - Anthony Athanasios Provatas
University of Connecticut Center for Environmental Science and Engineering, Storrs, USA
41 shared publications - Daniel W. Rosenberg
Centre for Molecular Oncology, Carole and Ray Neag Comprehensive Cancer Center, School of Medicine, University of Connecticut Health, Farmington, USA
41 shared publications - Haleh Vaziri
Department of Gastroenterology and Hepatology, University of Connecticut, Farmington, USA
41 shared publications - James J. Grady
Department of Public Health Sciences, UConn Health, Farmington, Connecticut, USA
41 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S8: Baseline sociodemographic characteristics of 38 study participants based on urinary urolithin A production
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S8: Baseline sociodemographic characteristics of 38 study participants based on urinary urolithin A production
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Figure S2: Polyp tissues used for IMC analysis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Figure S2: Polyp tissues used for IMC analysis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S3: List of serum markers analyzed in the patients
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S3: List of serum markers analyzed in the patients
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S6: Urinary urolithin metabolomic data after enzymatic hydrolysis, as described under Materials and methods
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S6: Urinary urolithin metabolomic data after enzymatic hydrolysis, as described under Materials and methods
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S9 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S9: Non-hydrolyzed fecal urolithin A levels
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S9 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S9: Non-hydrolyzed fecal urolithin A levels
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Figure S1: Selection of study participants
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Figure S1: Selection of study participants
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S10 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S10: Representativeness of Study Participants
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S10 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S10: Representativeness of Study Participants
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S1: List of food items study participants were asked to avoid during the 7-day washout period and 3-week walnut supplementation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S1: List of food items study participants were asked to avoid during the 7-day washout period and 3-week walnut supplementation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S5: Polyp risk score association with urolithin production
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S5: Polyp risk score association with urolithin production
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S7: Adjusted dietary intake of 38 study participants based on urinary urolithin A production post walnut intervention
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S7: Adjusted dietary intake of 38 study participants based on urinary urolithin A production post walnut intervention